| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.16 | 0.21 | 0.20 | 0.10 | 0.08 |
| Long Term Debt-Equity Ratio | 0.08 | 0.10 | 0.09 | 0.04 | 0.01 |
| Current Ratio | 1.86 | 2.14 | 2.34 | 2.27 | 2.01 |
| Fixed Assets | 1.56 | 1.53 | 1.60 | 1.74 | 1.84 |
| Inventory | 4.15 | 3.70 | 3.38 | 3.30 | 3.69 |
| Debtors | 6.12 | 6.31 | 6.64 | 6.80 | 6.37 |
| Interest Cover Ratio | 20.38 | 8.59 | 17.20 | 104.18 | 124.99 |
| PBIDTM (%) | 23.62 | 21.08 | 17.64 | 23.80 | 30.72 |
| PBITM (%) | 19.85 | 17.08 | 13.70 | 19.94 | 27.07 |
| PBDTM (%) | 22.65 | 19.09 | 16.84 | 23.61 | 30.50 |
| CPM (%) | 16.06 | 13.73 | 12.63 | 19.68 | 25.85 |
| APATM (%) | 12.28 | 9.73 | 8.70 | 15.82 | 22.20 |
| ROCE (%) | 17.21 | 14.12 | 11.67 | 19.15 | 30.20 |
| RONW (%) | 12.39 | 9.81 | 8.91 | 16.82 | 27.06 |